US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.96

-0.2700-0.69%

Volume:279

Turnover:10.81K

Market Cap:7.79M

PE:- -

High:38.96

Open:39.22

Low:38.96

Close:39.23

52wk High:43.01

52wk Low:24.96

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.12

T/O Rate:0.14%

Dividend:0.32

Dividend Rate:0.82%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scholar Rock to Present at Canaccord Genuity Annual Growth Conference

Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG

Alkermes Plc : Jefferies Raises Target Price to $72 from $65

THOMSON REUTERS

Alkermes Plc : TD Cowen Raises Target Price to $58 from $57

THOMSON REUTERS

Alkermes Plc : Baird Raises Target Price to $58 from $48

THOMSON REUTERS

Brain-Computer Interface Startup Wabo Tech Secures Angel Funding with Hontai Capital's Participation

Wall Street Analysts Are Bullish on Top Healthcare Picks

Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)

Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary

Alkermes Releases Transcript of Q2 2026 Earnings Call

Alkermes sinks 5% to $50.05 following Q2 report

Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance

MT Newswires Live

Brain-Computer Interfaces Surge Against Market Turmoil: A Deep Dive Into Investment Opportunities

Alkermes Q2 Sales $496.009M Beat $457.818M Estimate

Benzinga Earnings

Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results

Brain-Computer Interface Commercialization Reaches Key Breakthrough, Concept Stocks Surge, and the "Sichuan Cohort" Gains Momentum

Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43

THOMSON REUTERS

Oppenheimer would own Capricor Therapeutics into committee meeting

Global Milestones Drive Brain-Computer Interface Closer to Commercial Breakthrough Year; A-Share and Hong Kong Stocks Rally, Sanbo Hospital Surges Over 12%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IBRN/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":38.9601,"timestamp":1788206400000,"preClose":39.2301,"halted":0,"volume":279,"delay":0,"changeRate":-0.006882470348023664,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.27,"latestTime":"09-01 08:06:09 EDT","open":39.22,"high":38.9601,"low":38.9601,"amount":10811,"amplitude":0,"askPrice":42.93,"askSize":100,"bidPrice":37.05,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":38.9601,"sharesOutstanding":150000,"nav":39.171708,"aum":7834341.6,"dividendRate":0.008201,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.2301,"preClose":38.9601,"latestTime":"16:10 EDT","volume":7,"amount":272.7207,"timestamp":1788207004390,"change":0.27,"changeRate":0.00693,"amplitude":0},"volumeRatio":0.12153684993369444,"impliedVol":0.124,"impliedVolPercentile":0.6693},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.12153684993369444,"shares":200000,"dividePrice":0.3195,"high":38.9601,"amplitude":0,"preClose":39.2301,"low":38.9601,"week52Low":24.9594,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":38.9601,"committee":-0.980198,"eps":0,"divideRate":0.008201,"volume":279,"delay":0,"ttmEps":0,"open":39.22,"prevYearClose":32.3193,"prevWeekClose":39.2301,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":39.5297,"twentyDayClose":36.6969,"sixtyDayClose":34.9273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655209867","title":"Scholar Rock to Present at Canaccord Genuity Annual Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2655209867","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655209867?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326450,"startTime":"0","endTime":"0","summary":"Scholar Rock to present at Canaccord Genuity Annual Growth ConferenceScholar Rock will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on Aug. 12, 2026 at 1:30 p.m. ET.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scholar Rock Holding Corporation published the original content used to generate this news brief via Business Wire  on July 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL2x2b6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","THNR","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655786130","title":"Praxis Precision Med Price Target Maintained with a $810.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2655786130","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655786130?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:41","pubTimestamp":1785321660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE0009355771.USD","LU0109394709.USD","BK4139","PRAX","LU0889565916.HKD","IBRN","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655385647","title":"Alkermes Plc : Jefferies Raises Target Price to $72 from $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2655385647","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655385647?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:45","pubTimestamp":1785303957,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","MEDX","FBT","BK4139","PSIL","PSCH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655855711","title":"Alkermes Plc : TD Cowen Raises Target Price to $58 from $57","url":"https://stock-news.laohu8.com/highlight/detail?id=2655855711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655855711?lang=en_us&edition=fundamental","pubTime":"2026-07-29 13:22","pubTimestamp":1785302541,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0HB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","BK4139","IBRN","FBT","PSCH","ALKS","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655853939","title":"Alkermes Plc : Baird Raises Target Price to $58 from $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2655853939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655853939?lang=en_us&edition=fundamental","pubTime":"2026-07-29 12:22","pubTimestamp":1785298959,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V062:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","FBT","PSIL","IBRN","PSCH","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186375979","title":"Brain-Computer Interface Startup Wabo Tech Secures Angel Funding with Hontai Capital's Participation","url":"https://stock-news.laohu8.com/highlight/detail?id=1186375979","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186375979?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:51","pubTimestamp":1785289892,"startTime":"0","endTime":"0","summary":"On the morning of July 29, non-invasive brain-computer interface (BCI) company Wabo Tech announced the completion of its angel round of financing. The investment institutions for this round include...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655884804","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655884804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655884804?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:00","pubTimestamp":1785261615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Incyte (INCY) with bullish senti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-264?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","FBT","PSCH","BK4588","BK4550","BK4585","BK4139","IDNA","BK4532","INCY","MEDX","ALKS","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655264886","title":"Alkermes Price Target Raised to $65.00/Share from $43.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2655264886","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655264886?lang=en_us&edition=fundamental","pubTime":"2026-07-29 00:10","pubTimestamp":1785255000,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALKS/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","PSCH","BK4139","IBRN","ALKS","MEDX","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654424888","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alkermes (ALKS) and Universal Health (UHS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2654424888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654424888?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:20","pubTimestamp":1785248424,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS) and Universal Health (UHS). Alkermes (ALKS) Needh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-alkermes-alks-and-universal-health-uhs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","UHS","IBRN","BK4581","BK4585","BK4139","BK4588","PSCH","LU0029874061.USD","XBI","PSIL","ALKS","FBT","MEDX","LABU","BK4137","HCSG","BK4185","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654700086","title":"Alkermes Plc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2654700086","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654700086?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:32","pubTimestamp":1785245569,"startTime":"0","endTime":"0","summary":"Alkermes Plc reports results for the quarter ended June 30 - Earnings SummaryAlkermes PlcALKS.OQreported quarterly breakeven results per share for the quarter ended June 30, lower than the same quarte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nL8N43U1WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","MEDX","IBRN","PSIL","FBT","PSCH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654071550","title":"Alkermes Releases Transcript of Q2 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2654071550","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654071550?lang=en_us&edition=fundamental","pubTime":"2026-07-28 21:17","pubTimestamp":1785244649,"startTime":"0","endTime":"0","summary":"Alkermes releases transcript of Q2 2026 earnings callAlkermes discussed Q2 2026 results on an earnings call attended by CEO Richard Pops, CFO Joshua Reed, CCO Todd Nichols, COO and incoming CEO Blair ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nNDL35dZmZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","PSIL","PSCH","MEDX","FBT","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007833","title":"Alkermes sinks 5% to $50.05 following Q2 report","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007833","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654007833?lang=en_us&edition=fundamental","pubTime":"2026-07-28 20:50","pubTimestamp":1785243027,"startTime":"0","endTime":"0","summary":"08:45 EDT Alkermes (ALKS) sinks 5% to $50.05 following Q2 report Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-sinks-5-to-50-05-following-q2-report-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSCH","BK4139","ALKS","FBT","IBRN","MEDX","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654100907","title":"Alkermes Q2 Earnings Flat, Revenue Rises; Reiterates 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2654100907","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654100907?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:42","pubTimestamp":1785238953,"startTime":"0","endTime":"0","summary":"Alkermes  reported break-even earnings for Q2 Tuesday, compared with earnings of $0.52 per share a year earlier.Analysts polled by FactSet expected a loss of $0.03.Total revenue for the quarter ended June 30 was $496 million, up from $390.7 million a year earlier.Analysts surveyed by FactSet expected $457.4 million.For 2026, Alkermes reiterated its total revenue guidance of $1.73 billion to $1.84 billion. Analysts polled by FactSet expected $1.81 billion.Shares of the company were up less than 1% in recent Tuesday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","MEDX","PSCH","FBT","PSIL","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112554479","title":"Brain-Computer Interfaces Surge Against Market Turmoil: A Deep Dive Into Investment Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1112554479","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112554479?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:20","pubTimestamp":1785237641,"startTime":"0","endTime":"0","summary":"On July 28th, the technology and growth sectors experienced a severe downturn, with the Shenzhen Component Index falling 4.52% and the ChiNext Index dropping over 7%. Amidst this gloomy sentiment,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006162","title":"Alkermes Q2 Sales $496.009M Beat $457.818M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006162","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006162?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:02","pubTimestamp":1785236572,"startTime":"0","endTime":"0","summary":"Alkermes (NASDAQ:ALKS) reported quarterly sales of $496.009 million which beat the analyst consensus estimate of $457.818 million by 8.34 percent.  This is a 26.97 percent increase over sales of $390.657 million the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60719288/alkermes-q2-sales-496-009m-beat-457-818m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","IBRN","FBT","PSIL","BK4139","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654006923","title":"Press Release: Alkermes Plc Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654006923","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654006923?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:00","pubTimestamp":1785236400,"startTime":"0","endTime":"0","summary":"DUBLIN--(BUSINESS WIRE)--July 28, 2026--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended June 30, 2026. To view the detailed second quarter 2026 earnings press releas","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4139","IBRN","ADHD","MEDX","FBT","PSIL","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101416851","title":"Brain-Computer Interface Commercialization Reaches Key Breakthrough, Concept Stocks Surge, and the \"Sichuan Cohort\" Gains Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1101416851","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101416851?lang=en_us&edition=fundamental","pubTime":"2026-07-28 17:21","pubTimestamp":1785230466,"startTime":"0","endTime":"0","summary":"A major milestone has been reached in the brain-computer interface (BCI) sector. ScienceCorp, a U.S.-based BCI company, has secured approval for its PRIMA retinal chip in the European Union, marking...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654502005","title":"Alkermes Plc : Piper Sandler Raises Target Price to $65 from $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2654502005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654502005?lang=en_us&edition=fundamental","pubTime":"2026-07-28 12:05","pubTimestamp":1785211555,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260728:nFWN43T1LE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBT","BK4139","MEDX","IBRN","PSIL","ALKS","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045069","title":"Oppenheimer would own Capricor Therapeutics into committee meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045069?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:20","pubTimestamp":1785162008,"startTime":"0","endTime":"0","summary":"After briefing documents for this Wednesday’s FDA advisory committee for deramiocel became available this morning, Oppenheimer analyst Leland Gersh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","SBIO","LABU","XBIX","PBE","FBT","IBRN","OPY","BK4585","BK4588","CAPR","BK4139","BK4127","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146757033","title":"Global Milestones Drive Brain-Computer Interface Closer to Commercial Breakthrough Year; A-Share and Hong Kong Stocks Rally, Sanbo Hospital Surges Over 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146757033","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146757033?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:13","pubTimestamp":1785154434,"startTime":"0","endTime":"0","summary":"After three consecutive days of declines, the A-share medical sector rebounded on July 27. The largest medical ETF in the market, Huabao Medical ETF (512170), closed up 2.54% with a turnover of 595...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["301293","MNTL","159828","IBRN","BK0236"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}